HTA229 PICO Criteria Applied in Joint Action 3 Differ From National HTA Requirements: A Review of Oncology Drug Assessments in Denmark, France, Germany, and Sweden
Abstract
Authors
M. Konstanski J. Gehrman J. Schepis Martinez K. Schmidt E. Wissinger H. Altmann